Chronic myelomonocytic leukemia (CMML) is a myeloid neoplasm characterized by dysplasia, abnormal production and accumulation of monocytic cells and an elevated risk to transform into acute leukemia. Over the past two decades, our knowledge about the pathogenesis and molecular mechanisms in CMML has increased substantially. In parallel, better diagnostic criteria and therapeutic strategies have been developed. However, many questions remain regarding prognostication and optimal therapy. In addition, there is a need to define potential pre-phases of CMML and special CMML variants, and to separate these entities from each other and from conditions mimicking CMML. To address these unmet needs, an international consensus group met in a Working Conference in August 2018 and discussed open questions and issues around CMML, its variants, and pre-CMML conditions. The outcomes of this meeting are summarized herein and include diagnostic criteria and a proposed classification of pre-CMML conditions as well as refined minimal diagnostic criteria for classical CMML and special CMML variants, including oligomonocytic CMML and CMML associated with systemic mastocytosis. Moreover, we propose diagnostic standards and tools to delineate between normal, pre-CMML and CMML entities. These criteria and standards should facilitate diagnostic and prognostic evaluations in daily practice and clinical studies in applied hematology.
Proposed diagnostic criteria for classical CMML, CMML variants and pre-CMML conditions / P. Valent, A. Orazi, M.R. Savona, M.M. Patnaik, F. Onida, A.A. van de Loosdrecht, D. Haase, T. Haferlach, C. Elena, L. Pleyer, W. Kern, T. Pemovska, G.I. Vladimer, J. Schanz, A. Keller, M. Lubbert, T. Lion, K. Sotlar, A. Reiter, T. De Witte, M. Pfeilstocker, K. Geissler, E. Padron, M. Deininger, A. Orfao, H. Horny, P.L. Greenberg, D.A. Arber, L. Malcovati, J.M. Bennett. - In: HAEMATOLOGICA. - ISSN 0390-6078. - 104:10(2019 Sep 30), pp. 1935-1949. [10.3324/haematol.2019.222059]
Proposed diagnostic criteria for classical CMML, CMML variants and pre-CMML conditions
F. Onida;
2019
Abstract
Chronic myelomonocytic leukemia (CMML) is a myeloid neoplasm characterized by dysplasia, abnormal production and accumulation of monocytic cells and an elevated risk to transform into acute leukemia. Over the past two decades, our knowledge about the pathogenesis and molecular mechanisms in CMML has increased substantially. In parallel, better diagnostic criteria and therapeutic strategies have been developed. However, many questions remain regarding prognostication and optimal therapy. In addition, there is a need to define potential pre-phases of CMML and special CMML variants, and to separate these entities from each other and from conditions mimicking CMML. To address these unmet needs, an international consensus group met in a Working Conference in August 2018 and discussed open questions and issues around CMML, its variants, and pre-CMML conditions. The outcomes of this meeting are summarized herein and include diagnostic criteria and a proposed classification of pre-CMML conditions as well as refined minimal diagnostic criteria for classical CMML and special CMML variants, including oligomonocytic CMML and CMML associated with systemic mastocytosis. Moreover, we propose diagnostic standards and tools to delineate between normal, pre-CMML and CMML entities. These criteria and standards should facilitate diagnostic and prognostic evaluations in daily practice and clinical studies in applied hematology.File | Dimensione | Formato | |
---|---|---|---|
1935.full.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
2.34 MB
Formato
Adobe PDF
|
2.34 MB | Adobe PDF | Visualizza/Apri |
Valent-et-al-CMML-R1-2019.pdf
accesso aperto
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
550.27 kB
Formato
Adobe PDF
|
550.27 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.